What If I Get Sick While on GLP-1 Medications?
Learn how to manage GLP-1 therapy during illness including the flu, stomach bugs, COVID, and other acute illnesses. Includes when to skip doses and when to call your doctor.
More on What If Questions
Important Medical Disclaimer
This article is for informational purposes only. If you are severely ill, unable to keep fluids down, or have concerning symptoms, seek immediate medical care regardless of your GLP-1 therapy status.
The Direct Answer
During mild illness, you can usually continue GLP-1 therapy. During moderate to severe illness -- especially with vomiting, diarrhea, or inability to eat -- you should delay your injection until you recover and stay aggressive about hydration.
The biggest risk when sick on semaglutide or tirzepatide is dehydration. GLP-1 medications already reduce fluid intake by suppressing appetite, and illness-related vomiting or diarrhea can compound this. Dehydration can lead to kidney injury, electrolyte imbalances, and hospitalization.
Sick Day Decision Guide
Mild Illness (Cold, Mild Allergies) -- Continue Treatment
If you can eat and drink normally with just congestion, sore throat, or mild fatigue, continue your GLP-1 injection as scheduled.
Moderate Illness (Flu, COVID, Mild GI Bug) -- Consider Delaying
If you have significant nausea, reduced eating, or mild vomiting/diarrhea, consider delaying your injection by 1-3 days until symptoms improve. Prioritize hydration.
Severe Illness (Severe GI Bug, High Fever, Unable to Eat) -- Skip and Call Provider
If you cannot keep fluids down, have severe GI symptoms, or have not eaten for 24+ hours, skip your injection and contact your healthcare provider for guidance.
Resuming Treatment After Illness
Wait Until You Can Eat Normally
Resume your injection only when you can eat and drink without difficulty for at least 24 hours.
Consider a Lower Dose
If you missed more than one dose, your provider may recommend restarting at a lower dose and re-titrating to reduce side effects.
Do Not Double Up
Never take a double dose to make up for a missed injection. Simply resume your regular dosing schedule.
Frequently Asked Questions
Should I skip my GLP-1 injection if I have the flu?
It depends on the severity. For mild cold or flu symptoms without significant nausea or vomiting, you can typically continue your injection. For moderate to severe illness with vomiting, diarrhea, or inability to eat, consider delaying your injection until you can eat and drink normally. Contact your provider for guidance.
Can GLP-1 medications make a stomach bug worse?
Yes. GLP-1 medications already cause nausea and slow gastric emptying. Adding a stomach virus on top of these effects can significantly worsen GI symptoms and increase dehydration risk. It is usually wise to delay your injection until the GI illness resolves.
How do I stay hydrated when sick on GLP-1 medications?
Sip fluids frequently rather than drinking large amounts at once. Electrolyte solutions (Pedialyte, Gatorade), bone broth, clear soups, and diluted juice are good options. Avoid ice-cold beverages which may worsen nausea. Aim for at least 48-64 oz of fluid daily.
When should I call my doctor about being sick on GLP-1 therapy?
Contact your provider if: you cannot keep fluids down for 12+ hours, you have not eaten for 24+ hours, you have a fever above 102F for more than 2 days, you experience severe abdominal pain, or if you are diabetic and your blood sugar is unstable.
Can I take OTC cold and flu medications with GLP-1s?
Most OTC medications (acetaminophen, ibuprofen, antihistamines, cough suppressants) are safe with GLP-1 therapy. However, GLP-1 medications may delay absorption of oral medications due to slower gastric emptying. Avoid NSAIDs if you have kidney concerns. Always check with your pharmacist.
Get Ongoing Medical Support With Your GLP-1 Therapy
Our providers are available to guide you through sick days and dosing questions. Semaglutide from $99/mo, tirzepatide from $125/mo.
Explore Treatment OptionsSources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).